Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Trial With Complementary Therapies During Chemotherapy at the Women's Hospital of the University of Heidelberg

NCT00160901 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT00160901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00160901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Trial With Complementary Therapies During Chemotherapy at the Women's Hospital of the University of Heidelberg
Lead sponsor
Heidelberg University
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2003
Completion date
December 31, 2005
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer